Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Published Date: 19 Oct 2025

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More cancer cases in areas where incarceration rates are high: Study

2.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

3.

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

4.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

5.

Adopted cancer cells and the effects of their presence.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot